Kadcyla 160mg Injection
By Kadcyla
Rx
1 Injection in a Vial

Composition
Ado-trastuzumab emtansine(160mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
April, 2026
About Kadcyla 160mg Injection
Kadcyla 160mg Injection is a medication used to treat early and metastatic breast cancer, specifically targeting certain types of breast cancer known as human epidermal growth factor receptor 2 (HER-2) positive. These are types of breast cancer that have spread to other parts of the body and have not responded well to other cancer medications.
This drug is administered through an injection by a qualified medical professional. Your doctor will determine the appropriate dosage and frequency of administration based on your specific condition. It is crucial to follow your doctor's instructions precisely, as incorrect usage or overdose can lead to severe side effects. It may take some time before you notice the benefits of the medication, so it is important not to discontinue treatment without your doctor's approval.
Common side effects of Kadcyla 160mg Injection include tiredness, nausea, musculoskeletal pain, and bleeding. This medication can also lower the number of blood cells in your body, increasing the risk of infections. Regular blood tests are necessary to monitor your blood cell counts, as well as your heart, liver, and blood uric acid levels.
Before starting this treatment, inform your doctor if you have heart disease, liver or kidney issues, or if you are taking any medications for infections. It is crucial to disclose all medications you are currently using, as they can interact with Kadcyla. This medication is not recommended for use during pregnancy or breastfeeding. Both males and females are advised to use effective contraception during treatment to prevent pregnancy.
Benefits
Kadcyla 160mg Injection offers significant benefits in the treatment of both Early Breast Cancer and Metastatic Breast Cancer. In the case of Early Breast Cancer, this medication is effective in addressing the initial stages of the disease, either on its own or in conjunction with other treatments like chemotherapy. It works by alleviating symptoms such as breast lumps, unusual discharge from the nipples, or changes in breast shape or texture. Importantly, Kadcyla 160mg Injection targets and eliminates cancer cells, as well as hinders their ability to multiply.
For patients with Metastatic Breast Cancer, Kadcyla 160mg Injection proves to be a valuable option when previous treatments have not yielded significant results and the cancer has spread to other parts of the body. Similarly, it helps relieve distressing breast cancer symptoms while targeting and halting the growth of cancer cells.
It is essential for individuals using Kadcyla 160mg Injection to have open discussions with their healthcare providers concerning any potential side effects that may arise. By understanding the benefits of this medication in combating breast cancer, patients can make informed decisions about their treatment plan and overall well-being.
How to use the Kadcyla 160mg Injection
To use Kadcyla 160mg Injection, it is important to follow your doctor or nurse's instructions closely. This medication should not be self-administered, so it is essential to have a healthcare professional give you the injection. Typically, the injection will be administered in a medical setting such as a hospital or clinic. It is important to communicate any concerns or questions you may have with your healthcare provider before receiving the injection. By following your healthcare provider's guidance, you can ensure the safe and effective use of Kadcyla to help with your medical condition.
Uses of Kadcyla 160mg Injection
Uses:
Kadcyla 160mg Injection is primarily indicated for the treatment of early breast cancer and metastatic breast cancer. In cases of early breast cancer, Kadcyla is used as an adjuvant treatment following surgery to reduce the risk of cancer recurrence. It targets HER2-positive breast cancer, which is known to be more aggressive but also has specific treatment options like Kadcyla.
For patients with metastatic breast cancer, Kadcyla is employed as a second-line therapy after other treatments have been tried. This drug is designed to specifically target cancer cells with the HER2 receptor, which may help to slow down the progression of the disease and improve overall outcomes. By targeting the cancer cells more precisely, Kadcyla aims to reduce the side effects often associated with traditional chemotherapy while still being effective in treating the cancer.
What conditions Kadcyla 160mg Injection treats?
Kadcyla 160mg Injection is utilized in managing both early and metastatic breast cancer. Specifically targeting certain forms of breast cancer, it is designed for cases of human epidermal growth factor receptor 2 (HER-2) that have spread to other organs and have not responded to previous cancer treatments. Administered as an injection by a qualified healthcare professional, the dosage and frequency are determined by your doctor based on individual needs. Side effects may include tiredness, nausea, musculoskeletal pain, and potential reduction in blood cell levels, requiring regular blood tests during treatment. Precaution is advised for those with heart, liver, or kidney issues, and effective contraception is crucial to prevent pregnancy during treatment.
Should you consult a doctor?
If you experience any persistent or concerning symptoms while taking Kadcyla 160mg Injection, it is important to seek medical attention promptly. Contact your doctor if you have ongoing tiredness, nausea, musculoskeletal pain, or bleeding. Additionally, if you notice symptoms such as persistent headaches, liver issues, constipation, nosebleeds, or any unusual changes in your health, it is advisable to consult your healthcare provider.
Furthermore, if you develop any signs of low blood platelets or have concerns about your blood cell levels, including experiencing unusual bruising or bleeding, it is crucial to notify your doctor immediately. Regular blood tests are necessary to monitor these levels.
Remember to inform your healthcare team about any pre-existing conditions like heart disease, liver or kidney issues, and any other medications you are taking to ensure safe usage of Kadcyla. If you are pregnant, planning pregnancy, or breastfeeding, discuss suitable contraceptive measures with your doctor to avoid potential risks.
Always adhere to your doctor's instructions on dosages and administration of Kadcyla to minimize the risk of serious side effects and to maximize the benefits of the treatment.
Side effects of Kadcyla 160mg Injection
When using Kadcyla 160mg Injection, some common side effects may occur as your body gets used to the medication. These side effects include tiredness, nausea, musculoskeletal pain (related to bones, muscles, or joints), bleeding, low blood platelets, headache, liver disorder, constipation, and nosebleeds. In most cases, these side effects do not need medical treatment as they often go away on their own. However, if any of these side effects persist or if you have concerns about them, it is important to consult your doctor for proper guidance and evaluation.
Safety advice

liver
When using Kadcyla 160mg Injection, it is important to be cautious if you have severe liver disease. Patients with severe liver issues may require a dose adjustment when taking Kadcyla 160mg Injection. It is advised to consult your doctor regarding the appropriate use of this medication in case of liver problems.

kidney
There is limited information available on using Kadcyla 160mg Injection in patients with kidney disease. It is important to consult your doctor regarding the use of this medication in such cases.

alcohol
Consult your doctor when consuming alcohol with Kadcyla 160mg Injection.

driving
When using Kadcyla 160mg Injection, it is typically safe to drive as it does not usually impact your driving abilities.

pregnancy
Kadcyla 160mg Injection should not be used during pregnancy due to potential risks to the baby. In life-threatening situations, a doctor may consider its use if benefits outweigh risks. Consult your doctor.

breastfeeding
Kadcyla 160mg Injection is not safe to use while breastfeeding as it may harm the baby.
Consumption warning before consuming Kadcyla 160mg Injection
Before using Kadcyla 160mg Injection, it is crucial to follow your doctor's instructions carefully as improper usage can lead to severe side effects. This medication is specifically designed to treat certain types of breast cancer (HER-2 positive) that have spread and not responded to other treatments. Given as an injection by a qualified healthcare provider, the dosage and frequency will be determined by your doctor based on your condition. It is essential to take it exactly as prescribed to avoid complications. While the benefits may take some time to become noticeable, do not discontinue the treatment without consulting your doctor.
Common side effects may include tiredness, nausea, musculoskeletal pain, and the potential for decreased blood cell count, which can increase the risk of infections. Regular blood tests are necessary to monitor your blood cell levels, heart, liver, and blood uric acid levels. Inform your healthcare provider about any existing heart, liver, or kidney conditions, as well as any ongoing medications, to prevent potential interactions. It is advised to avoid pregnancy during treatment and to use effective contraception for both men and women.
What if you forgot to take Kadcyla 160mg Injection?
If you forget to take a dose of Kadcyla 160mg Injection, it is important to speak with your doctor right away. Missing a dose can impact the effectiveness of your treatment, so it's crucial to seek guidance from your healthcare provider on how to proceed. Consulting your doctor will help determine the best course of action to manage the missed dose and maintain the optimal treatment plan for your condition.
Related lab tests
For patients taking Kadcyla 160mg Injection, it is important to monitor certain lab tests to assess their response to treatment and manage potential side effects. The related lab tests include CA 15.3, ER (estrogen receptor), and PR (progesterone receptor) levels. CA 15.3 is a tumor marker that can be elevated in some cases of breast cancer, and monitoring its levels can help track the progression of the disease. ER and PR levels indicate whether the cancer cells have receptors for estrogen and progesterone, which can help guide treatment decisions. Regular monitoring of these lab tests can provide valuable information to healthcare providers to optimize the treatment plan for patients with breast cancer undergoing therapy with Kadcyla 160mg Injection.
Additional Information
Habit Forming | No |
Chemical Class | Monoclonal Antibody |
Therapeutic Class | - |
Action Class | HER2/neu (ErbB2) Inhibitor- Monoclonal antibody |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹248937
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025